Screener
Solid Biosciences Inc. SLDB Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -65.5%+2.7pp | -57.4%-2.1pp | -109.9%-15.3pp | -86.8%-21.0pp | -68.2%-17.4pp | |
| Return on invested capital | -112.5%+5.8pp | -191.5%-65.3pp | -161.1%+1.1pp | -111%-20.5pp | -118.3%-27.5pp | |
| Liquidity | ||||||
| Current ratio | 13.8×+4.5× | 13.1×+2.2× | 6.1×+0.9× | 6.7×-1.1× | 9.3×-4.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $2.60-5.1% | $3.41-23.2% | $2.06-38.8% | $2.31-42.7% | $2.74-41.9% | |
| Valuation | ||||||
| Market capitalization | $857.5M+69.9% | $708.42M+147% | $439.41M+175% | $480.45M+78.6% | $376.34M+72.9% | |
| Price / book | 2.3×+0.3× | 1.9×+0.9× | 2.4×+1.3× | 2.2×+0.6× | 1.5×+0.3× |
FAQ
- Where do Solid Biosciences Inc.'s ratios come from?
- Every ratio is computed from Solid Biosciences Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.